Welcure Drugs & Pharmaceuticals Ltd
Newspaper Clipping of Audited Financials Results for the 4th Quarter and Annual year ended 31st March, 2026.
RESULTS
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 01 Jun 2026, 12:42 PM IST · BSE ID: 194fda64-cb9e-4098-8ce2-45fcaee3dbab
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a profit of Rs. 0.05 Lakh in its latest quarter and Rs. 0.09 Lakh for the full year.
🤖 AI Summary
- Net Profit for Welcure Drugs & Pharmaceuticals Ltd was Rs. 0.05 Lakh for Q4 FY26.
- Total Income for the quarter ended March 31, 2026, reached Rs. 0.49 Lakh.
- Annual Net Profit for the fiscal year ended March 31, 2026, was Rs. 0.09 Lakh.
- Total Income for the full fiscal year 2026 stood at Rs. 0.52 Lakh.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net Profit for Q4 FY26
Rs. 0.05 Lakh
Total Income for Q4 FY26
Rs. 0.49 Lakh
Net Profit for FY26
Rs. 0.09 Lakh
Total Income for FY26
Rs. 0.52 Lakh
🏢 How This Affects the Company
The company reported a Net Profit of Rs. 0.05 Lakh for Q4 FY26 and Rs. 0.09 Lakh for the full FY26. Total income for Q4 FY26 was Rs. 0.49 Lakh, and for FY26, it was Rs. 0.52 Lakh.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as these results provide an overview of the company's financial performance for Q4 and the full fiscal year ended March 31, 2026.
🔍
Management Signal
The reporting of audited financial results for Q4 and the annual year ended March 31, 2026, demonstrates management's adherence to regulatory disclosure requirements.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1 FY27 results — assess any change in revenue and profit trends.
Further financial disclosures — monitor for operational scale increases.
Any strategic business updates — evaluate plans for growth.
MEDIUM RISK
The company exhibits very low revenue and profit figures, indicating limited business scale.
💡 Investor Takeaway
Welcure Drugs & Pharmaceuticals Ltd reported a Net Profit of Rs. 0.05 Lakh on a Total Income of Rs. 0.49 Lakh for Q4 FY26. For the full FY26, Net Profit was Rs. 0.09 Lakh with Total Income of Rs. 0.52 Lakh.
⚖️ Strengths & Concerns
✅ Positives
- The company reported a Net Profit of Rs. 0.05 Lakh for the quarter ended March 31, 2026, indicating positive earnings.
- For the full fiscal year ended March 31, 2026, the company achieved a Net Profit of Rs. 0.09 Lakh.
⚠️ Concerns
- Total Income for the quarter ended March 31, 2026, was Rs. 0.49 Lakh, representing a low revenue base.
- Total Income for the full fiscal year ended March 31, 2026, was Rs. 0.52 Lakh, indicating limited scale of operations.
📅 Company Track Record
No previous filings found for Welcure Drugs & Pharmaceuticals Ltd, indicating limited public financial track record available.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Welcure Drugs & Pharmaceuticals Ltd's Net Profit for Q4 FY26?
Welcure Drugs & Pharmaceuticals Ltd reported a Net Profit of Rs. 0.05 Lakh for the quarter ended March 31, 2026.
What was the Total Income for Welcure Drugs & Pharmaceuticals Ltd in Q4 FY26?
The Total Income for Welcure Drugs & Pharmaceuticals Ltd for the quarter ended March 31, 2026, was Rs. 0.49 Lakh.
What was Welcure Drugs & Pharmaceuticals Ltd's annual Net Profit for FY26?
For the full fiscal year ended March 31, 2026, Welcure Drugs & Pharmaceuticals Ltd's Net Profit was Rs. 0.09 Lakh.
What was the Total Income for Welcure Drugs & Pharmaceuticals Ltd for the full fiscal year 2026?
The Total Income for Welcure Drugs & Pharmaceuticals Ltd for the full fiscal year ended March 31, 2026, was Rs. 0.52 Lakh.
Questions based on this BSE filing only. For information purposes.